Pacific Biosciences of California, Inc.PACBNASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P41
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -1.94% |
| Q3 2025 | 36.32% |
| Q2 2025 | 33.32% |
| Q1 2025 | -43.74% |
| Q4 2024 | 32.58% |
| Q3 2024 | 16.22% |
| Q2 2024 | 28.30% |
| Q1 2024 | -31.37% |
| Q4 2023 | 11.62% |
| Q3 2023 | -34.18% |
| Q2 2023 | 48.70% |
| Q1 2023 | -56.34% |
| Q4 2022 | 3.94% |
| Q3 2022 | -4.11% |
| Q2 2022 | 23.37% |
| Q1 2022 | -149.24% |
| Q4 2021 | 22.01% |
| Q3 2021 | -158.76% |
| Q2 2021 | 31.99% |
| Q1 2021 | -61.99% |
| Q4 2020 | 19.91% |
| Q3 2020 | 25.14% |
| Q2 2020 | -131.57% |
| Q1 2020 | 514.54% |
| Q4 2019 | -5.33% |
| Q3 2019 | 1.70% |
| Q2 2019 | 30.63% |
| Q1 2019 | -33.33% |
| Q4 2018 | -33.93% |
| Q3 2018 | 2.22% |
| Q2 2018 | 22.78% |
| Q1 2018 | 7.06% |
| Q4 2017 | -13.24% |
| Q3 2017 | -39.26% |
| Q2 2017 | 23.16% |
| Q1 2017 | -29.21% |
| Q4 2016 | 18.74% |
| Q3 2016 | 15.93% |
| Q2 2016 | 6.82% |
| Q1 2016 | -2738.52% |